The invention relates to a compound of a general formula (I): wherein A represents a linking group； Ar1 represents a group formed from an aromatic ring； R1 and R2 each independently represent a hydrogen atom, a halogen atom, a cyano group, a C2-C6 alkenyl group, a C1-C6 alkoxy group, a halo-C1-C6 alkoxy group, a cyclo-C3-C6 alkyloxy group, a C2-C7 alkanoyl group, a halo-C2-C7 alkanoyl group, a C2-C7 alkoxycarbonyl group, a halo-C2-C7 alkoxycarbonyl group, a cyclo-C3-C6 alkyloxycarbonyl group, an aralkyloxycarbonyl group, a carbamoyl-C1-C6 alkoxy group, a carboxy-C2-C6 alkenyl group, or a group of -Q1-N(Ra)-Q2-Rb； a C1-C6 alkyl group optionally having substituent(s)； an aryl or heterocyclic group optionally having substituent(s)； or a C1-C6 alkyl group or a C2-C6 alkenyl group having the aryl or heterocyclic group； T and U each independently represent a nitrogen atom or a methine group； and V represents an oxygen atom, a sulfur atom or an imino group. The compound of the invention is useful as therapeutical agents for various ACC-related diseases.
